For more information
Ernest A. Bates, M.D., Chairman and CEO
email: eabates@ashs.com

American Shared Hospital Services
Two Embarcadero Center, Suite 410
San Francisco, CA 94111

Gamma Knife Perfexion System Supplied by American Shared Hospital Services Begins Treating Patients at Sacred Heart Health System in Pensacola, Florida

San Francisco, CA, March 28, 2013 -- AMERICAN SHARED HOSPITAL SERVICES (NYSE MKT:AMS), a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, announced today that the Gamma Knife® Perfexion™ system it supplied to Sacred Heart Health System in Pensacola, Florida has begun treating patients.

Noting that Sacred Heart is a new hospital affiliation for American Shared, AMS Chairman and Chief Executive Officer Ernest A. Bates, M.D., said, "This latest addition to our Perfexion portfolio demonstrates that neurosurgeons and radiation oncologists who know the competing technologies best continue to demand this unequaled stereotactic radiosurgery system for treating cancers and other diseases of the brain. We see additional opportunities to place Gamma Knife Perfexions at new and existing AMS sites both in the U.S. and internationally."

AMS, the largest owner of Gamma Knife Perfexion systems worldwide, has now placed twelve Perfexion systems in the United States and one in Turkey; a fourteenth system is scheduled to be installed at Northern Westchester Hospital in Mt. Kisco, New York in the second quarter.

About Gamma Knife Perfexion

Gamma Knife Perfexion maintains full clinical compatibility with the classic Gamma Knife and is supported by efficacy and outcome data from 600,000 treated patients worldwide and thousands of peer-reviewed scientific articles, making it a proven choice for radiosurgery of the brain. According to its manufacturer, Elekta, Gamma Knife Perfexion reduces unwanted body dose to the patient by up to 100 times compared with competing technologies, which is particularly important for treatment of children and women of childbearing age, and allows for a dramatically increased treatable volume, which is expected to increase the number of patients that can benefit from Gamma Knife surgery. Elekta estimates that the fully automated and efficient single push-button approach can save 3-5 working weeks of physician time per year at an average Gamma Knife center.

About AMS

American Shared Hospital Services provides turnkey technology solutions for advanced radiosurgical and radiation therapy services. AMS is the world leader in providing Gamma Knife radiosurgery equipment, a non-invasive treatment for malignant and benign brain tumors, vascular malformations and trigeminal neuralgia (facial pain). The Company also offers the latest IGRT and IMRT systems, as well as its proprietary Operating Room for the 21st CenturySM concept. AMS owns a preferred stock investment in Mevion Medical Systems, Inc., developer of the compact MEVION S250 Proton Therapy System.

Safe Harbor Statement

This press release may be deemed to contain certain forward-looking statements with respect to the financial condition, results of operations and future plans of American Shared Hospital Services, which involve risks and uncertainties including, but not limited to, the risks of the Gamma Knife and radiation therapy businesses, the risks of developing The Operating Room for the 21st Century program, and the risks of investing in a development-stage company, Mevion Medical Systems, Inc., without a proven product. Further information on potential factors that could affect the financial condition, results of operations and future plans of American Shared Hospital Services is included in the filings of the Company with the Securities and Exchange Commission, including the Company's Annual Report on Form 10-K for the year ended December 31, 2011, the Quarterly Report on form 10-Q for the quarter ended March 31, 2012, the Quarterly Reports on Form 10-Q and 10-Q/A for the quarter ended June 30, 2012, the Quarterly Report on form 10-Q for the quarter ended September 30, 2012, and the definitive Proxy Statement for the Annual Meeting of Shareholders held on June 7, 2012.

Back to Top